Dutch AI Startup Raises €2.3 Million to Predict Surgical Infections Before They Happen
Netherlands, Saturday, 7 February 2026.
Healthplus.ai secured funding to accelerate deployment of PERISCOPE®, an artificial intelligence system that predicts patient-specific infection risks after surgery and provides targeted preventive actions for healthcare teams. The technology could save hospitals up to €4 million annually by reducing postoperative complications while decreasing workload on medical staff, representing a significant advancement in predictive healthcare.
Healthcare Technology Innovation
This development represents a significant advancement in healthcare technology, specifically in the medtech sector [GPT]. Healthplus.ai has developed PERISCOPE®, an artificial intelligence system designed to predict patient-specific infection risks following surgical procedures and provide targeted preventive actions for healthcare teams [1]. The MedTech scale-up completed its funding round in February 2026, securing €2.3 million to accelerate the rollout of this predictive healthcare technology [1]. The funding was led by Elevating Capital and LUMO Labs, with additional participation from Pathena Venture Capital, Leistone (Renza Family), and ROM InWest [1].
Financial Impact and Market Opportunity
The economic implications of PERISCOPE® are substantial, with the system capable of saving hospitals up to €4 million annually by addressing postoperative complications, which represent a significant cost burden and source of workload pressure in healthcare facilities [1]. The technology addresses a critical need in the healthcare transformation landscape, where the imperative is to achieve better patient outcomes with fewer interventions [1]. Dr. Bart Geerts, CEO and founder of Healthplus.ai, emphasized that this late seed investment strengthens the company’s ability to integrate clinically validated, regulatory-approved AI into daily hospital practice [1]. The system’s integration capabilities with electronic patient record (EPD) systems that serve the Dutch and broader European markets, including Epic, Oracle Cerner, and ChipSoft, position it for rapid adoption across healthcare networks [1].
Technology Implementation and Market Expansion
PERISCOPE® demonstrates significant technical advantages through its automatic calibration feature, ensuring accurate predictions across different types of hospitals while maintaining regulatory compliance [1]. The system’s seamless integration capability with existing hospital infrastructure makes it rapidly adoptable within current healthcare workflows [1]. Healthplus.ai plans to utilize the funding to accelerate European expansion and initiate operations in the United States market [1]. The company is also investing in further development of AI risk models for all phases of surgical procedures, indicating a comprehensive approach to perioperative care management [1].
Regional Innovation Ecosystem
The success of Healthplus.ai reflects the broader innovation capabilities of North Holland’s Life Sciences & Health and AI ecosystem [1]. Sara Schaafsma, Investment Manager at ROM InWest, highlighted the company’s potential impact on patient stratification, enabling healthcare providers to create better treatment plans, intervene more quickly with high-risk patients, and safely discharge low-risk patients earlier [1]. This approach facilitates faster patient recovery, makes specialist work more efficient, and reduces strain on the healthcare system [1]. ROM InWest, in collaboration with Amsterdam knowledge institutions, leads efforts to organize and guide regional cooperation in this sector [1]. The investment connects capital and networks to a North Holland scale-up that demonstrates the region’s combination of world-class AI capabilities and Life Sciences & Health expertise, positioning it for international breakthrough [1].